Paul J. Hastings, Chairman & CEO at OncoMed Pharmaceuticals Inc (OMED), sold 12,898 shares at $9.06 ($117K) on 2017-04-04, disclosed to the SEC on 2017-04-05.
Open-market sale of $117k OMED by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.87 | 48 | $426 | 0.4% |
| 2 | $9.06 | 6,425 | $58K | 49.8% |
| 3 | $9.06 | 6,425 | $58K | 49.8% |
| Total | $9.06 avg | 12,898 | $117K | 100% |
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |